Frequency of Malignant Pleural Mesothelioma in Patients with Massive Pleural Effusion Admitted in Pulmonology Ward Mardan Medical Complex Mardan

Authors

  • Farmanullah Mardan Medical Complex, KP, Pakistan.
  • Sajjad Ali Mardan Medical Complex, KP, Pakistan.
  • Zeeshan Bahadur Mardan Medical Complex, KP, Pakistan.
  • Imtiaz Ahmad Mardan Medical Complex, KP, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i6.1636

Keywords:

Malignant Pleural Mesothelioma, Massive Pleural Effusion, Histopathology

Abstract

Background: Malignant pleural mesothelioma is an uncommon cancer that has a strong link to asbestos exposure. It is not well understood why mesothelioma develops in patients with large pleural effusion. This study provided the frequency of malignant pleural mesothelioma in patients with massive pleural effusion and identified demographic and clinical risk factors associated with its development. Objective: To determine the frequency of malignant pleural mesothelioma in patients with massive pleural effusion admitted in pulmonology ward Mardan Medical Complex Mardan. Study Design: Cross-sectional study. Duration and Place of Study: The study was conducted from December 15, 2024, to May 15, 2025, at the Department of Pulmonology, Mardan Medical Complex, Mardan. Methodology: A total of 112 patients of age 18 to 70 years with massive pleural effusion were selected. Pleural tissue specimens were obtained via percutaneous needle biopsy or thoracoscopic biopsy, and histopathological analysis with immunohistochemical staining was used to diagnose mesothelioma. Results: The mean age of participants was 47.67 ± 14.11 years, with a male predominance (61.6%). Mesothelioma was diagnosed in 9 patients (8%). Statistically significant associations were found between mesothelioma and older age (>50 years), male gender, BMI >30 kg/m², symptom duration >12 weeks, and rural residency. Conclusion: Malignant pleural mesothelioma is a significant cause of massive pleural effusion in patients over 50 years of age, predominantly affecting males with a higher BMI.

Downloads

Download data is not yet available.

References

Tiwari, N., Kumbhare, R., & Walke, R. R. (2022). Physical therapy rehabilitation for a chronic alcoholic patient with Loculated pleural effusion. Cureus.

https://doi.org/10.7759/cureus.30368

Bediwy, A. S., Al-Biltagi, M., Saeed, N. K., Bediwy, H. A., & Elbeltagi, R. (2023). Pleural effusion in critically ill patients and intensive care setting. World Journal of Clinical Cases, 11(5), 989-999.

https://doi.org/10.12998/wjcc.v11.i5.989

Christopher, D. J., Gupta, R., Thangakunam, B., Daniel, J., Jindal, S. K., Kant, S., Chhajed, P. N., Gupta, K. B., Dhooria, S., Chaudhri, S., Chaudhry, D., Patel, D., Mehta, R., Chawla, R. K., Srinivasan, A., Kumar, A., Bal, S. K., James, P., Roger, J. S., … Kurien, R. B. (2024). Pleural effusion guidelines from ICS and NCCP section 1: Basic principles, laboratory tests and pleural procedures. Lung India, 41(3), 230-248.

https://doi.org/10.4103/lungindia.lungindia_33_24

Karpathiou, G., Péoc'h, M., Sundaralingam, A., Rahman, N., & Froudarakis, M. E. (2022). Inflammation of the Pleural Cavity: A Review on Pathogenesis, Diagnosis and Implications in Tumor Pathophysiology. Cancers, 14(6), 1415.

https://doi.org/10.3390/cancers14061415

Wijayaratne, T., Yousuf, A., & Panchal, R. (2024). Cardiac related pleural effusions: a narrative review. Journal of Thoracic Disease, 16(2).

https://doi.org/10.21037/jtd-23-1731

Yang, L., & Wang, Y. (2023). Malignant pleural effusion diagnosis and therapy. Open Life Sciences, 18(1).

https://doi.org/10.1515/biol-2022-0575

Ferreiro, L., Casal, A., Toubes, M. E., Suárez-Antelo, J., Golpe, A., Abelleira-París, R., Riveiro, V., Álvarez-Dobaño, J. M., & Valdés, L. (2022). Pleural effusion due to nonmalignant gastrointestinal disease. ERJ Open Research, 9(3), 00290-2022.

https://doi.org/10.1183/23120541.00290-2022

Guo, L., Zhang, Q., Lv, C., Ma, X., Song, X., Huang, J., Chen, W., Li, C., & Ding, Q. (2022). A novel biomarker for pleural effusion diagnosis: Interleukin?36? in pleural fluid. Journal of Clinical Laboratory Analysis, 37(1).

https://doi.org/10.1002/jcla.24799

Wadowski, B., De Rienzo, A., & Bueno, R. (2020). The Molecular Basis of Malignant Pleural Mesothelioma. Thoracic Surgery Clinics, 30(4), 383-393.

https://doi.org/10.1016/j.thorsurg.2020.08.005

Jain, M., Crites, M. K., Rich, P., & Bajantri, B. (2024). Malignant pleural mesothelioma: A comprehensive review. Journal of Clinical Medicine, 13(19), 5837.

https://doi.org/10.3390/jcm13195837

Sejben, A., Pancsa, T., Tiszlavicz, L., Furák, J., Paróczai, D., & Zombori, T. (2023). Highlighting the immunohistochemical differences of malignant mesothelioma subtypes via case presentations. Thoracic Cancer, 14(10), 857-863.

https://doi.org/10.1111/1759-7714.14827

Brims, F. (2021). Epidemiology and Clinical Aspects of Malignant Pleural Mesothelioma. Cancers, 13(16), 4194.

https://doi.org/10.3390/cancers13164194

Musso, V., Diotti, C., Palleschi, A., Tosi, D., Aiolfi, A., & Mendogni, P. (2021). Management of Pleural Effusion Secondary to Malignant Mesothelioma. Journal of Clinical Medicine, 10(18), 4247-4247.

https://doi.org/10.3390/jcm10184247

Hassan, M., Touman, A. A., Grabczak, E. M., Skaarup, S. H., Faber, K., Blyth, K. G., & Pochepnia, S. (2024). Imaging of pleural disease. Breathe (Sheffield), 20(1), 230172-230172.

https://doi.org/10.1183/20734735.0172-2023

Ge, S., Zhao, Y., Liang, J., He, Z., Li, K., Zhang, G., Hua, B., Zheng, H., Guo, Q., Qi, R., & Shi, Z. (2024). Immune modulation in malignant pleural effusion: from microenvironment to therapeutic implications. Cancer Cell International, 24(1).

https://doi.org/10.1186/s12935-024-03211-w

Bakhshayesh Karam, M., Karimi, S., Mosadegh, L., & Chaibakhsh, S. (2016). Malignant Mesothelioma Versus Metastatic Carcinoma of the Pleura: A CT Challenge. Iranian Journal of Radiology, 13(1).

https://doi.org/10.5812/iranjradiol.10949

O'donovan, P. B., & Eng, P. (1994). Pleural changes in malignant pleural effusions: appearance on computed tomography. Cleveland Clinic Journal of Medicine, 61(2), 127-131.

https://doi.org/10.3949/ccjm.61.2.127

Shirzadi, A., Ahmadinejad, I., Ahmadinejad, M., Hatami, S., Soltanian, A., & Ahmadinejad, Y. (2025). Investigation of the Prevalence of Chronic Pulmonary Effusion Causes and Response to Treatment (Pleurodesis) in Patients. The Open Respiratory Medicine Journal, 19(1).

https://doi.org/10.2174/011GCrs81X4NCxPQRTkjwMQXjiBKtK5p19

Gönlügür, U., Seyfikli, Z., Efeo?lu, T., Y?ld?z, E., & Nadir, A. (2003). Malignant Mesothelioma Causing Transudative Pleural Effusion. Turkish Respiratory Journal, 4(3), 164-166.

Rehan, M., Alam, M. T., Imran, K., Farrukh, S. Z. U. I., Masroor, M., & Kumar, P. (2013). The frequency of various diseases in patients presenting with pleural effusion. Gomal Journal of Medical Sciences, 11(1).

https://www.gjms.com.pk/index.php/journal/article/view/449

Downloads

Published

2025-06-26

How to Cite

Farmanullah, Ali, S., Bahadur, Z., & Ahmad, I. (2025). Frequency of Malignant Pleural Mesothelioma in Patients with Massive Pleural Effusion Admitted in Pulmonology Ward Mardan Medical Complex Mardan. Indus Journal of Bioscience Research, 3(6), 440-444. https://doi.org/10.70749/ijbr.v3i6.1636